Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms - Wikidata - awgldk - TriplyDB

Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms

Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms

http://www.wikidata.org/entity/Q41912237

about

Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms Antifungal lock therapy Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.In vitro activity of anidulafungin against Candida albicans biofilms Quinacrine inhibits Candida albicans growth and filamentation at neutral pH.Candida parapsilosis, an emerging fungal pathogen Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.The effect of antifungal combination on transcripts of a subset of drug-resistance genes in clinical isolates of Candida species induced biofilms.In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.Novel strategies to fight Candida species infection.Fungal biofilm resistance.Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature.Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents.Favorable outcome of neonatal cerebrospinal fluid shunt-associated Candida meningitis with caspofungin.Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children.Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility.Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections?Antifungal susceptibility of Candida albicans in biofilms.Echinocandins: are they all the same?Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.Hampered by historical paradigms--echinocandins and the treatment of Candida endocarditis.Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces.Novel strategies against Candida biofilms: interest of synthetic compounds.Management of Candida biofilms: state of knowledge and new options for prevention and eradication.Genetic Drivers of Multidrug Resistance in Candida glabrata.The postantifungal and paradoxical effects of echinocandins against Candida spp.Azole-resistant Candida albicans prosthetic joint infection treated with prolonged administration of anidulafungin and two-stage exchange with implant of a mega-prosthesis.Efficacy of anidulafungin in the treatment of experimental Candida parapsilosis catheter infection using an antifungal-lock technique.Differential effects of antifungal agents on expression of genes related to formation of Candida albicans biofilms.Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production.Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates.Candida parapsilosis osteomyelitis.Elevated chitin content reduces the susceptibility of Candida species to caspofungin.Fungal echinocandin resistance.Growth Inhibition and Membrane Permeabilization of Candida lusitaniae Using Varied Pulse Shape Electroporation.

P2860

Q26861656-5E6287A1-61C3-4D7D-BD30-E4ACD2970762 Q27025682-88B90E30-567F-4C40-B352-450D47ADA41B Q28533912-2EAC64E8-B28C-4D85-B634-31DAC4AD8127 Q34024546-4ED7B391-DDF0-4F35-8B40-495DB0AAA1DB Q34058104-8E38938C-A800-459A-A6D8-336A35E2DBBB Q34590099-6931AB20-5792-48D0-AFB5-311D99862AD7 Q34597683-F23E790B-A65C-4CF9-BF87-F88CC1E64295 Q34852747-DFE72BE0-5144-4443-BE49-F9E573FA5BFD Q34932922-A2459C54-C789-48D4-B198-E60775BA279A Q35028539-F88E429D-E295-4791-B09F-138483C81956 Q35152853-2A50AFCC-DB4D-4E39-A97C-887EF4F41DC9 Q35406737-447773EE-E7B0-4B59-A1F3-07914F6F296E Q35821475-DA0E9EB9-369D-4AAC-85AF-CBE73458E320 Q35959489-46A25A78-2F72-44AC-8A8C-E44E4C842005 Q36283867-43F29146-97AE-4B31-933A-D330EAB81E1B Q36785910-9418ACA4-C3F7-473C-A7EA-6040C88D610D Q36933366-318AFE11-B322-49FF-8C42-F4BDCC59D293 Q37026730-98931B1C-3932-40F7-A2A7-BC4B8DC25B92 Q37242216-2DC305AA-0DB3-412C-A45C-7B7000488624 Q37392907-B6756508-1BD5-4504-A4FE-1594D46F75FC Q37613000-DFC48030-D032-43E5-B8A5-8366BAB9571F Q37854724-FCD213B8-4FBE-4A5D-ADEF-7F6B1A57D073 Q37906758-64DB1962-77CF-42BB-86BF-B19055C3AD2C Q37974743-368EAB23-BCF7-4CBB-94A9-802AAAE4BDC2 Q38149163-7E011B20-B078-413F-880C-F8A5216363EC Q38164120-A1003282-1F2B-4CE4-ACB6-817AD3C2176D Q38633105-5F229074-5CC0-4B07-BC9F-F697D99E8704 Q38670904-C8F46D5D-7D8F-466D-838F-2E0E2F351176 Q38724208-B7D05E2D-86A5-4863-943F-DF3520C365BD Q39065051-92D5FE35-6FC5-4909-8318-3E16DE819F9A Q39619972-704316F8-E5A5-49A3-825A-461D3EB0686B Q40606434-22FB8282-20C4-4F81-B374-56A08CEA888D Q40625328-E6619F87-65A3-43DD-BAB4-C2CAD893F801 Q40900363-E7013EA6-CDFB-4278-B791-7D2910C7524C Q40920367-B87FF4C6-5053-46A4-9461-DBC854981603 Q41168995-86747811-BDCF-4061-B9BA-966A859D1B5F Q41699308-3B3623DE-7012-45BB-A340-45522EE9A101 Q41843284-046D0710-53D9-4492-BFB4-9DAA37D1449F Q41848811-DD6BB609-DDFC-4D3C-B734-84853D233EE6 Q42178504-2DD8BF5E-87AB-41A3-9B7B-F72A61D7204B

P2860

Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms

http://www.wikidata.org/entity/Q41912237

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Differential activities of new ...... Candida parapsilosis biofilms

@en

type

label

Differential activities of new ...... Candida parapsilosis biofilms

@en

prefLabel

Differential activities of new ...... Candida parapsilosis biofilms

@en

P1433

Q41912237-09EB4B08-0761-43D7-B26F-5A29731F0E27

P1476

Q41912237-D2951DFA-E4E4-4F76-A3CB-47DEA67543BB

P2093

Q41912237-2E5F57FD-9682-4E0A-9A1A-7D62BBE093F4

Q41912237-3E0F317F-E19C-49FF-81E0-9D3A57A614D5

Q41912237-5A0F5BCC-25FF-4D5E-9ED0-6063D40E6F5A

Q41912237-5A160CC5-3C5E-4D07-8A09-29C675ABDE89

Q41912237-D8B8A2C4-97D5-468C-8303-3F4C9F415C53

Q41912237-E9DB9B12-1522-4C0C-A639-D9B0A1789D38

P2860

Q41912237-060F8A6A-3037-46CB-B9E0-83A86B934430

Q41912237-2252C7EC-7846-46B7-ADC1-961253B39A36

Q41912237-2E9DEEBB-5291-4CBC-B441-0DBFC715372C

Q41912237-34B32A6E-7304-43DF-889E-91D5BCE4EFC9

Q41912237-3BE36A4A-45EC-456B-93F7-F2958D52C0F5

Q41912237-58A6C8CD-93AB-4839-A07F-6A7BEFC5F61C

Q41912237-70A7520F-DB22-4C18-92A6-BD51B54080DE

Q41912237-8982B1D1-437B-401E-BEFD-0E1AD6BFDA6E

Q41912237-9774CA11-52DD-4BEA-8E25-5EFDEBD7BC93

Q41912237-9EEB0884-C089-4B6F-9C8F-8F51C7598513

P304

Q41912237-5BAB6EB8-CD70-4881-89C8-A4EF44070FB2

P31

Q41912237-15559C78-9A77-4F33-83DF-FA40FCC2292C

P356

Q41912237-A93847C4-5001-4BA3-B0F9-201F03321C62

P407

Q41912237-0A36D60D-4220-4BBA-806A-0870AEFF8F46

P433

Q41912237-73C9AD0D-6761-4FCB-8C16-3C5E75210C50

P478

Q41912237-A7555A24-013B-42B3-AE8B-DE8008190EBE

P50

Q41912237-9CF28EA3-2C8D-40ED-80D3-66CD7682ED19

P577

Q41912237-50A668E4-1367-483B-983F-3884A9DF904D

P5875

Q41912237-C95B0C86-9E8C-4B66-9738-A309A42FF6C3

P698

Q41912237-40EB43EF-4C1D-4027-8634-E7D9AA16833A

P921

Q41912237-13AFBCC1-8B7C-4E90-AD69-9067F86EDA19

P932

Q41912237-DBAFD12C-97A7-4F3E-A8CF-D70EA69F4F4D

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Differential activities of new ...... Candida parapsilosis biofilms

@en

P2093

Aspasia Katragkou

http://www.w3.org/2001/XMLSchema#string

Athanasios Chatzimoschou

http://www.w3.org/2001/XMLSchema#string

Chaido Tsantali

http://www.w3.org/2001/XMLSchema#string

Eudoxia Diza-Mataftsi

http://www.w3.org/2001/XMLSchema#string

Maria Dalakiouridou

http://www.w3.org/2001/XMLSchema#string

Maria Simitsopoulou

http://www.w3.org/2001/XMLSchema#string

P2860

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

In vitro activity of caspofungin against Candida albicans biofilms.

Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolat

Evaluation of endpoints for antifungal susceptibility determinations with LY303366.

Candida biofilms and their susceptibility to antifungal agents.

Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.

Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus

Candida biofilm resistance.

P304

357-360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00856-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Emmanuel Roilides

P577

2007-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5907642

http://www.w3.org/2001/XMLSchema#string

P698

17938192

http://www.w3.org/2001/XMLSchema#string

P921

P932

2223899

http://www.w3.org/2001/XMLSchema#string